ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,928.39
0.19%
Dow Jones
43,774.20
0.84%
US Dollar vs MXN
20.36636
0.42%
Brent Oil
73.615
1.06%
Bitcoin
96,790.34
2.58%
Pepperstone
Advertisement
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ

  6. SciSparc Ltd (SPRC) Cotización

SciSparc Ltd

SciSparc Ltd (SPRC)

NASDAQ
0.2344
-0.0037
( -1.55% )
Actualizado: 09:55:18
Delayed by 15 minutes

Herramientas de nivel profesional para inversores individuales.

Premium

Estadísticas y detalles clave

Último Precio
0.2344
Postura de Compra
0.2345
Postura de Venta
0.241
Volume Operado de la Acción
77,108
0.234 Rango del Día 0.2449
0.2055 Rango de 52 semanas 14.2199
Capitalización de Mercado [m]
633.741k
Precio Anterior
0.2381
Precio de Apertura
0.2381
Hora
4
@
0.2345
Última hora de negociación
09:56:38
Volumen financiero
US$ 18,237
Precio Promedio Ponderado
0.236511
Volumen promedio (3 m)
972,587
Acciones en circulación
2,703,674
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-0.13
Beneficio por acción (BPA)
-1.89
turnover
2.88M
Beneficio neto
-5.12M

Acerca de SciSparc Ltd

SciSparc Ltd is a specialty clinical-stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The compa... SciSparc Ltd is a specialty clinical-stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company operates in the single segment of the Development of drugs based on cannabinoid molecules to be approved by an official regulatory authority. Mostrar más

Sector
Pharmaceutical Preparations
Industria
Pharmaceutical Preparations
Sitio web
scisparc.com
Sede
Tel Aviv, Center, Isr
Fundado
-
SciSparc Ltd is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker SPRC. The last closing price for SciSparc was US$0.24. Over the last year, SciSparc shares have traded in a share price range of US$ 0.2055 to US$ 14.2199.

SciSparc currently has 2,703,674 shares in issue. The market capitalisation of SciSparc is US$643,744.78 . SciSparc has a price to earnings ratio (PE ratio) of -0.13.

SPRC Últimas noticias

Más noticias

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

04 Noviembre 2024
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

23 Octubre 2024
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

22 Octubre 2024
Edgar (US Regulatory)

SciSparc Secures FDA Green Light to US Launch of its Pivotal Phase IIb Clinical Trial for Breakthrough Tourette Syndrome Treatment

FDA confirms that SciSparc’s study may proceed only a month after application submission TEL AVIV, Israel, Sept. 30, 2024 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("Company" or...

30 Septiembre 2024
GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

27 Septiembre 2024
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

26 Septiembre 2024
Edgar (US Regulatory)

SciSparc Signs Non-Binding Letter of Intent to Sell Stake in MitoCareX

The intended selling valuation represents an increase of 47% from the valuation at the time of SciSparc’s initial investment in MitoCareX Bio TEL AVIV, Israel, Sept. 26, 2024 (GLOBE NEWSWIRE...

26 Septiembre 2024
GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

23 Septiembre 2024
Edgar (US Regulatory)

SciSparc Receives FDA Approval to Initiate Phase IIb Clinical Trial for Tourette Syndrome Treatment

FDA confirms that SciSparc’s study may proceed following the application submission a month ago TEL AVIV, Israel, Sept. 23, 2024 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("Company" or...

23 Septiembre 2024
GlobeNewswire Inc.

SciSparc Takes Major Step Forward with IND Application submitted to the FDA for Phase IIb Clinical Trial for Tourette Syndrome Treatment

Yale Child Study Center at the Yale School of Medicine in the USA, Hannover Medical School in Germany and Tel Aviv Sourasky Medical Center in Israel will take part in the trial TEL AVIV, Israel...

18 Septiembre 2024
GlobeNewswire Inc.
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
1-0.0045-1.883633319380.23890.24490.21252682810.23161342CS
4-0.0016-0.6779661016950.2360.25540.21063730520.23506349CS
12-0.1156-33.02857142860.350.38460.20559725870.2708939CS
26-0.9756-80.62809917361.211.310.205520624200.46024239CS
52-5.7156-96.06050420175.9514.21990.205515649332.16022525CS
156-181.7656-99.8712087912182184.080.2055157426414.98767615CS
260-181.7656-99.8712087912182184.080.2055157426414.98767615CS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
WORXSCWorx Corporation
US$ 1.87
(90.82%)
102.31M
CRNCCerence Inc
US$ 5.25
(86.17%)
28.9M
BDRXBiodexa Pharmaceuticals PLC
US$ 6.42
(66.75%)
1.05M
SPAISafe Pro Group Inc
US$ 4.5315
(41.61%)
37.97M
NKGNNKGen Biotech Inc
US$ 0.42
(34.19%)
1.3M
PYXSPyxis Oncology Inc
US$ 2.06
(-46.07%)
8.89M
KURAKura Oncology Inc
US$ 9.90
(-37.77%)
7.26M
BLRXBioLineRx Ltd
US$ 0.357
(-34.52%)
5.51M
SHOTWSafety Shot Inc
US$ 0.1001
(-33.27%)
2.5k
APLMApollomics Inc
US$ 0.1109
(-25.97%)
4.76M
CDTConduit Pharmaceuticals Inc
US$ 0.1106
(19.83%)
475.34M
NVDANVIDIA Corporation
US$ 144.17
(-1.18%)
190.92M
AKTSAkoustis Technologies Inc
US$ 0.104
(19.40%)
179.81M
ELABElevai Labs Inc
US$ 0.0203
(-5.14%)
127.06M
WORXSCWorx Corporation
US$ 1.8799
(91.83%)
102.31M

SPRC Discussion

Ver más
Awl416 Awl416 2 meses hace
Fall for it if ya want

SciSparc Signs Non-Binding Letter of Intent to Sell Stake in MitoCareX
👍️0
Monksdream Monksdream 2 meses hace
SPRC new 52;week low
👍️0
Monksdream Monksdream 2 meses hace
SPRC new 52 week low
👍️0
Monksdream Monksdream 2 meses hace
SPRC new 52 week low

👍️0
Awl416 Awl416 3 meses hace
Talk about jumping off a cliff…
👍️0
glenn1919 glenn1919 3 meses hace
SPRC.............................https://stockcharts.com/h-sc/ui?s=SPRC&p=W&b=5&g=0&id=p86431144783
👍️0
Pastor Phil Pastor Phil 3 meses hace
I’m sold out
👍️0
webprods webprods 3 meses hace
Great news today. 1.63 coming
👍️0
webprods webprods 3 meses hace
32.63% pm . Actual
👍️0
Pastor Phil Pastor Phil 3 meses hace
Up over 30% premarket
👍️0
webprods webprods 3 meses hace
OS is only 7.36 million. 7,360,000
👍️0
webprods webprods 3 meses hace
Here you are. As of August 15, 2024, SciSparc Ltd. (SPRC) stock had 7.36 million shares outstanding. The company's public float was 2.45 million. Good luck. Closer to merger higher share price. I think that double dollars is possible
👍️0
Pastor Phil Pastor Phil 3 meses hace
Some spike on the newz here. Is it dun?
👍️0
Awl416 Awl416 3 meses hace
Oh stop it
👍️0
Awl416 Awl416 3 meses hace
Wasn’t rocket science
👍️0
hondaboost hondaboost 3 meses hace
Anyone could tell SPRC O/S, please? Thanks.
👍️0
Awl416 Awl416 3 meses hace
Yawn….
👍️0
glenn1919 glenn1919 3 meses hace
SPRC..........................https://stockcharts.com/h-sc/ui?s=SPRC&p=W&b=5&g=0&id=p86431144783
👍️0
BeamMeUpScotty BeamMeUpScotty 3 meses hace
They’re putting the deal to a shareholder vote. Sounds like they have agreed terms and just have to give the required amount of time for shareholders to vote for the deal.
👍️0
Awl416 Awl416 3 meses hace
Don’t fall for it…
👍️0
Monksdream Monksdream 3 meses hace
SPRC new 52 week low
👍️0
Monksdream Monksdream 4 meses hace
SPRC new 52 week low
👍️0
glenn1919 glenn1919 4 meses hace
SPRC........................https://stockcharts.com/h-sc/ui?s=SPRC&p=W&b=5&g=0&id=p86431144783
👍️0
Monksdream Monksdream 5 meses hace
SPRC new 52 week low
👍️0
Monksdream Monksdream 5 meses hace
SPRC new 52 week low
👍️0
Monksdream Monksdream 5 meses hace
SPRC new 52 week low
👍️0
Monksdream Monksdream 6 meses hace
SPRC 10Q expected 5/30
👍️0
Monksdream Monksdream 7 meses hace
SPRC new 52 lo

👍️0
Monksdream Monksdream 7 meses hace
SPRC new 52 lo
👍️0
DK11 DK11 7 meses hace
Totally scam got me a little. Out
👍️0
Monksdream Monksdream 7 meses hace
SPRC new 52 lo totally ridiculous
👍️0
DK11 DK11 7 meses hace
Go for it !!!
I just get pissed when Benzinga has Great News comes out for CVKD, BSFC, and SPRC and they all immediately go down
and I mean far down. So, you can't even trust good news now, to me it's time to take a rest. That's stepping over the line.
👍️0
Monksdream Monksdream 7 meses hace
But what about the gold and silver mining stocks which have been in rally mode since February
👍️0
DK11 DK11 7 meses hace
Less of two evils, I will take Trump Like Hungarian President said there was no war but peace with Trump inflation under control, and
The Stock Market for Traders was much better.
Yes, Trump was better.
👍️0
peterus peterus 7 meses hace
you think TRUMP is ?
👍️0
DK11 DK11 7 meses hace
Hey everyone, this stock is so good. Every time I go on my screener where I check over 1,000 stocks, usually I see a sea of red. This is a great time to get out of stock trading til we get a competent President. I am done for now
👍️0
Awl416 Awl416 7 meses hace
Fluff….
👍️0
Monksdream Monksdream 7 meses hace
Here we go again
Another boing off a 52 low due to another fluff news release
👍️0
Monksdream Monksdream 7 meses hace
SPRC new 52 lo
👍️0
Monksdream Monksdream 8 meses hace
SPRC under $2
👍️0
HoldEm777 HoldEm777 8 meses hace
Got to be getting close to turning…
👍️0
Awl416 Awl416 8 meses hace
SciSparc: MitoCareX Unveils Groundbreaking Discovery of Small Molecule Structure in Anti-Cancer Research

Fluffy - Keep trying
👍️0
Awl416 Awl416 8 meses hace
Below 1.85 lights out
👍️0
Awl416 Awl416 8 meses hace
Red!
👍️0
Awl416 Awl416 8 meses hace
Yawn….
👍️0
Monksdream Monksdream 8 meses hace
SPRC No 3 on the Barchart 100
https://www.barchart.com/stocks/performance/percent-change/advances?orderBy=percentChange&orderDir=desc
👍️0
Monksdream Monksdream 8 meses hace
SPRC new 52 lo
👍️0
Monksdream Monksdream 8 meses hace
SPRC new 52 week low
👍️0
TheFinalCD TheFinalCD 8 meses hace
https://classic.clinicaltrials.gov/ct2/show/NCT05182697
👍️0
TheFinalCD TheFinalCD 8 meses hace
$SPRC *AUTISM* NEWS https://www.globenewswire.com/news-release/2024/03/08/2843039/0/en/SciSparc-Announces-Enrollment-of-First-Patient-for-its-Clinical-Trial-for-Children-with-Autism-Spectrum-Disorder.html
👍️0

Su Consulta Reciente

NASDAQ
SPRC
SciSparc
LSE
IONQ
3x Long Ionq
BIT
1NOKIA
Nokia
BIT
1QCOM
Qualcomm
ASX
JAV
Javelin Minerals
BIT
HER
Hera
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados